C4 therapeutics to present at the 40th annual j.p. morgan healthcare conference

Watertown, mass., jan. 03, 2022 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced that the company will present at the 40th annual j.p. morgan healthcare conference on monday, january 10, 2022 at 10:30 a.m. est.
CCCC Ratings Summary
CCCC Quant Ranking